Grant: Knowledge Synthesis Grant
Unity Health Toronto
$90,000.00
Optimizing the timely initiation of aspirin prophylaxis in pregnancy based on risk factors in a prior and current pregnancy. A knowledge synthesis grant.
FY 2014-15
Summary
Few methods exist to prevent preeclampsia (PE) & related adverse perinatal outcomes. The relevance for parents, the child & society is immense. Randomized clinical trials (RCTs) established that aspirin (ASA) prophylaxis starting at 12-16 weeks of pregnancy reduces the risk of these adverse outcomes, especially PE. Major Canadian oversight bodies recommend ASA prophylaxis among “high risk” mothers. Yet, we currently lack a sufficient tool for clinicians to identify, in early pregnancy, such high-risk women. This gap in knowledge will be addressed by this Knowledge Synthesis grant.
For those who provide prenatal care to women (physicians, midwives & nurses), we will produce a ready-to-use set of risk factors that enable one to optimally identify women at high risk of PE who should be started on ASA. We will develop an end-user tool for clinicians & regional public health units.
We will complete a systematic pooled analysis of the risk factors for PE identified within observational studies (Step 1, Objectives 1a & 1b). We will then systematically examine the published RCTs to determine the relative risk of ASA vs. placebo, stratified by maternal risk factors (Step 2, Objective 2). We will complete a two-round RAND/UCLA panel method, including a policy roundtable meeting (Step 3, Objective 3), followed by the creation & dissemination of a simple, end-user handout and APP that identifies women at high risk for PE and outlines who warrants ASA prophylaxis (Steps 4a/4b, Objectives 4a/4b).
Our team comprises scientific & policy informants who define care priorities & practice guidelines for the care of pregnant women & infants. They include Marilyn Booth (Principal Knowledge User, Executive Director of the Ontario Provincial Council for Maternal & Child Health); Jennifer Blake (President of SOGC); John Kingdom (Chair, Dept. of Obstetrics & Gynaecology at U of T and Co-author of the SOGC Guideline on “Intrauterine Growth Restriction”); Vicki Van Wagner (Midwife & member of Clinical Practice Guideline Subcommittee of the Association of Ontario Midwives); Lisa Graves (Chair, Maternal & Newborn Care Program Committee, College of Family Physicians of Canada [CFPC]). Our team members agree that we need a better method of identifying, at the individual & population level, women at high risk of PE, in which ASA prophylaxis is warranted. Hence, we have the skills & expert users to complete an evidence-informed health prevention program that is likely to reduce the rates of PE and related preterm birth, fetal growth restriction & perinatal death.
After completion of Steps 1-4 (i.e., after dissemination of the tool and completion of this proposed ASA Knoweldge Synthesis initiative), we may decide to evaluate changes in the annual prevalence of PE, prematurity, stillbirth & SGA, using existing BORN Ontario datasets. If proven successful in Ontario, then by partnering with SOGC, Canadian Association of Midwives, CFPC, Canadian Perinatal Surveillance System & individual provincial perinatal groups, we could share this tool with other provincial obstetrics, midwifery, family medicine and perinatal surveillance groups.
Department
Program
Knowledge Synthesis Grant
Recipient
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
308780
Name
Ray Joel G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Knowledge Synthesis Grant
Projecttitle
Optimizing the timely initiation of aspirin prophylaxis in pregnancy based on risk factors in a prior and current pregnancy. A knowledge synthesis grant.
Programtype2
Operating Grants
Orgnameinp2
Unity Health Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Asa; Aspirin Prophylaxis; Hypertension In Pregnancy; Maternal And Newborn Health; Placenta; Preeclampsia; Pregnancy; Prenatal Care; Small For Gestational Age (Sga); Stillbirth
Abstract
<html>
<body>
<p>Few methods exist to prevent preeclampsia (<em>PE</em>) & related adverse perinatal outcomes. The relevance for parents, the child & society is immense. Randomized clinical trials (RCTs) established that aspirin (ASA) prophylaxis starting at 12-16 weeks of pregnancy reduces the risk of these adverse outcomes, especially <em>PE. </em> Major Canadian oversight bodies recommend ASA prophylaxis among “high risk” mothers. Yet, we currently lack a sufficient tool for clinicians to identify, in early pregnancy, such high-risk women. This gap in knowledge will be addressed by this Knowledge Synthesis grant.<br>
<br>For those who provide prenatal care to women (physicians, midwives & nurses), we will produce a ready-to-use set of risk factors that enable one to optimally identify women at high risk of <em>PE </em>who should be started on ASA. We will develop an end-user tool for clinicians & regional public health units.<br>
<br>We will complete a systematic pooled analysis of the risk factors for <em>PE</em> identified within observational studies (Step 1, Objectives 1a & 1b). We will then systematically examine the published RCTs to determine the relative risk of ASA vs. placebo, stratified by maternal risk factors (Step 2, Objective 2). We will complete a two-round RAND/UCLA panel method, including a policy roundtable meeting (Step 3, Objective 3), followed by the creation & dissemination of a simple, end-user handout and APP that identifies women at high risk for <em>PE</em> and outlines who warrants ASA prophylaxis (Steps 4a/4b, Objectives 4a/4b).<br>
<br>Our team comprises scientific & policy informants who define care priorities & practice guidelines for the care of pregnant women & infants. They include Marilyn Booth (Principal Knowledge User, Executive Director of the Ontario Provincial Council for Maternal & Child Health); Jennifer Blake (President of SOGC); John Kingdom (Chair, Dept. of Obstetrics & Gynaecology at U of T and Co-author of the SOGC Guideline on “Intrauterine Growth Restriction”); Vicki Van Wagner (Midwife & member of Clinical Practice Guideline Subcommittee of the Association of Ontario Midwives); Lisa Graves (Chair, Maternal & Newborn Care Program Committee, College of Family Physicians of Canada [CFPC]). Our team members agree that we need a better method of identifying, at the individual & population level, women at high risk of <em>PE</em>, in which ASA prophylaxis is warranted. Hence, we have the skills & expert users to complete an evidence-informed health prevention program that is likely to reduce the rates of <em>PE</em> and related preterm birth, fetal growth restriction & perinatal death.<br>
<br>After completion of Steps 1-4 (i.e., <span data-mce-style="text-decoration: underline;" style="TEXT-DECORATION: underline">after</span> dissemination of the tool and completion of this proposed ASA Knoweldge Synthesis initiative), we may decide to evaluate changes in the annual prevalence of <em><em>PE</em></em>, prematurity, stillbirth & SGA, using existing BORN Ontario datasets. If proven successful in Ontario, then by partnering with SOGC, Canadian Association of Midwives, CFPC, Canadian Perinatal Surveillance System & individual provincial perinatal groups, we could share this tool with other provincial obstetrics, midwifery, family medicine and perinatal surveillance groups.</p>
</body>
</html>
Competitiondate
201404
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ray, Joel G; Booth, Marilyn B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $90,000~ $0~